Everolimus

Everolimus is a medication used to treat certain types of kidney, brain, and lung cancers, as well as other conditions. It belongs to a class of medications called mTOR inhibitors, which work by blocking signals that tell cells to divide and grow. Everolimus is used to treat advanced renal cell carcinoma (kidney cancer) that has spread to other parts of the body. It is also used to treat progressive, well-differentiated pancreatic neuroendocrine tumors (NETs) and subependymal giant cell astrocytomas (SEGAs), which are noncancerous tumors in the brain. In addition, it is used to treat renal angiomyolipoma, a type of noncancerous tumor in the kidney.

Everolimus is a prescription medication used for several purposes, including preventing organ rejection after transplant, treating certain cancers, and suppressing tumor growth in some conditions. Here's a breakdown of its key features:

Function:

  • Everolimus belongs to a class of drugs called mammalian target of rapamycin (mTOR) inhibitors. mTOR is a protein pathway involved in cell growth and proliferation. By inhibiting mTOR, Everolimus can suppress the growth and division of cancer cells and prevent the immune system from attacking a transplanted organ.

Applications:

  • Preventing Organ Rejection: Everolimus is used in combination with other immunosuppressant medications to prevent the body from rejecting a transplanted kidney, heart, or liver.
  • Cancer Treatment: Everolimus is used to treat certain types of cancer, including:
    • Advanced kidney cancer (renal cell carcinoma)
    • Subependymal giant cell astrocytoma (SEGA), a type of brain tumor
    • Some types of breast cancer (in combination with other medications)
  • Tuberous Sclerosis Complex (TSC): Everolimus can be used to treat subependymal nodules and giant cell angiofibromas, which are tumors that can occur in people with TSC, a genetic condition.

Dosage and Administration:

  • Everolimus comes in tablet form and is typically taken once daily with or without food. The specific dosage will depend on the condition being treated, the patient's weight and overall health, and any other medications they are taking.

Side Effects:

Everolimus can cause several side effects, including:

  • Mouth sores
  • Fatigue
  • Diarrhea
  • Loss of appetite
  • Rash
  • Increased risk of infection
  • Increased cholesterol levels
  • Pneumonitis (inflammation of the lungs)

Important Considerations:

  • Everolimus can interact with other medications, so it's crucial to disclose your complete medical history and current medications to your doctor before starting Everolimus therapy.
  • Women who are pregnant or breastfeeding should not take Everolimus due to the risk of birth defects.
  • Everolimus can suppress the immune system, making you more susceptible to infections. It's important to practice good hygiene and tell your doctor if you develop any signs of infection.

Remember: This information is for general knowledge only. If you have any questions or concerns about Everolimus, consult with a healthcare professional. They can provide personalized advice based on your individual needs and medical history.

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01E - Protein kinase inhibitors
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AA Selective immunosuppressants
External Links